When you read about the Monsanto Roundup lawsuit, one particular detail sticks in your memory: John Durnell, a regular Missourian, picked up a bottle of weed killer, just like millions of Americans do every weekend. He did not oversee thousands of acres as a farmer. He was an individual attempting to maintain the cleanliness of his property. The label on that bottle made no mention of cancer, and years later, he was diagnosed with non-Hodgkin’s lymphoma. Not a single word.
One of the most significant legal disputes the Supreme Court has seen in years is now centered on that silence. Over 100,000 lawsuits, more than $10 billion in settlements, and a direct conflict between state consumer protection laws and federal regulatory authority have resulted from Monsanto’s failure to alert consumers about the purported cancer risks of glyphosate, the active ingredient in Roundup. It’s the kind of legal drama that, although sounding technical on paper, touches on a very human issue: who is in charge of alerting you to potential dangers?
| Category | Details |
|---|---|
| Company Name | Monsanto Company (now owned by Bayer AG) |
| Founded | 1901, St. Louis, Missouri |
| Headquarters | St. Louis, Missouri, USA (Bayer AG: Leverkusen, Germany) |
| Product in Dispute | Roundup Herbicide (active ingredient: Glyphosate) |
| Acquired By | Bayer AG in 2018 for approximately $63 billion |
| Total Settlements Paid | Over $10 billion to settle roughly 100,000 claims |
| Case at the Supreme Court | Monsanto Company v. Durnell (argued April 27, 2026) |
| Original Plaintiff | John Durnell, Missouri, filed in 2019 |
| Jury Award to Durnell | $1.25 million in compensatory damages |
| Federal Law in Question | Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA), originally passed in 1947 |
| EPA’s Position | Glyphosate does not pose a public health risk |
| WHO/IARC Classification | “Probably carcinogenic to humans” (2015) |
| Expected Court Decision | Early July 2026 |
| Reference | U.S. EPA Glyphosate Overview |
The foundation of Monsanto’s defense has always been a simple claim. Since 1974, the Environmental Protection Agency has conducted numerous reviews of glyphosate and has consistently determined that it does not cause cancer. States are prohibited by federal law, specifically FIFRA, from requiring pesticide labels to include information beyond what the EPA requires. Monsanto contends that even if it had wanted to, it could not have legally added a cancer warning if the EPA had not mandated one. The business is not concealing anything in that framing. It’s abiding by the regulations.
If the science were less disputed, the argument might be more persuasive. However, in 2015, the World Health Organization’s International Agency for Research on Cancer categorized glyphosate as “probably carcinogenic to humans.” The litigation floodgates were opened by that one report. Similar outcomes were observed in lab rats in a 2025 study. Tens of thousands of cancer patients have filed their cases in the uncomfortable space created by the discrepancy between what one significant international health body found and what the U.S. regulator has approved. The EPA has reviewed the IARC findings and continues to hold its position.
What Monsanto v. Durnell reveals about the boundaries of regulatory systems is what makes it truly fascinating. During the oral argument, Justice Ketanji Brown Jackson pointed out that the EPA may take up to 15 years to evaluate a particular pesticide. States may simply be reacting to new safety information faster than a federal agency, noted Chief Justice Roberts, who is not usually associated with consumer-side sympathy. These are not the words of a court prepared to give Monsanto a resounding win. Paul Clement, the lawyer for Monsanto, countered that the EPA’s slower pace is intentional because it considers not only hazard data but also the validity of the research itself.
The courtroom transcripts give the impression that even the justices are uncomfortable with the fundamental truth of this situation. Removing glyphosate from the market would endanger America’s food supply, according to the biggest farm organization in the nation. The chemical is hazardous, according to environmentalists. It’s safe, according to the EPA. Most likely not, according to the WHO. Additionally, a $1.25 million jury verdict for John Durnell in Missouri may be overturned by a court due to a 1947 federal statute that divides authority between the federal government and the states, not because the jury was mistaken about what happened to him.
As this develops, it’s difficult not to question whether a product label wasn’t the true source of this failure. Ordinary consumers are unsure about a product that is sold in almost every hardware store in America due to a combination of regulatory gaps, slow review cycles, and corporate legal strategy. The science will not be settled by the Supreme Court’s ruling, which is anticipated in early July 2026. However, it will determine who has the authority to take action when the science is still up for debate—federal agencies acting on their own schedule or state courts attending to individuals who are already ill.
